Chronic cerebral hypoperfusion (CCH) is common in vascular dementia, Alzheimer's disease, and related neurodegenerative disorders. It contributes to cognitive dysfunction, with synaptic loss as an important pathological event, but the underlying mechanisms remain unclear. Because chronic hypoperfusion, glial activation, and synaptic injury are increasingly implicated in Alzheimer's disease-related neurodegeneration, clarifying the mechanisms of CCH-induced synapse loss may also inform understanding of Alzheimer's disease.
Objective
To examine whether CCH promotes glia-associated synaptic marker accumulation and phagocytosis-related activity via damage-associated molecular patterns (DAMPs), and whether crocin can attenuate synaptic injury by suppressing this glial response.
Methods
Crocin was evaluated in vascular cognitive impairment patients, in a rat model of CCH, and in oxygen-glucose deprivation-treated glial cells. Cognitive function, neuroinflammation, synaptic injury, phagocytosis-related activity, complement-associated synaptic changes, autophagy-related alterations, lipid droplet accumulation, and NRF2-related mechanisms were assessed.
Results
Crocin improved cognitive function in patients with vascular cognitive impairment and in CCH rats, and reduced neuroinflammation. In experimental models, crocin attenuated microglial- and astrocyte-associated synaptic marker accumulation, suppressed pro-inflammatory activation and phagocytosis-related activity, downregulated MERTK and MEGF10, and reduced complement-associated synaptic vulnerability. Crocin also alleviated autophagy-related imbalance, oxidative stress, and lipid droplet accumulation in an NRF2-related manner.
Conclusions
Crocin may alleviate cognitive dysfunction after CCH by suppressing DAMPs-associated glial activation and glia-associated synaptic alterations, supporting its potential relevance to chronic hypoperfusion-related cognitive impairment.
CiacciarelliASetteGGiubileiF, et al.Chronic cerebral hypoperfusion: an undefined, relevant entity. J Clin Neurosci2020; 73: 8–12.
2.
DuncombeJKitamuraAHaseY, et al.Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia. Clin Sci2017; 131: 2451–2468.
3.
RajeevVChaiYLPohL, et al.Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment. Acta Neuropathol Commun2023; 11: 93.
4.
ZhaoYGongC-X. From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration. Cell Mol Neurobiol2014; 35: 101–110.
5.
LiNRenCLiS, et al.Remote ischemic conditioning alleviates chronic cerebral hypoperfusion-induced cognitive decline and synaptic dysfunction via the miR-218a-5p/SHANK2 pathway. Prog Neurobiol2023; 230: 102514.
6.
YaoZ-HWangJYuanJ-P, et al.EGB761 Ameliorates chronic cerebral hypoperfusion-induced cognitive dysfunction and synaptic plasticity impairment. Aging2021; 13: 9522–9541.
7.
NiuH-MMaD-LWangM-Y, et al.Epimedium flavonoids protect neurons and synapses in the brain via activating NRG1/ErbB4 and BDNF/Fyn signaling pathways in a chronic cerebral hypoperfusion rat model. Brain Res Bull2020; 162: 132–140.
8.
JearjaroenPThangwongPTocharusC, et al.Hexahydrocurcumin attenuates neuronal injury and modulates synaptic plasticity in chronic cerebral hypoperfusion in rats. Mol Neurobiol2023; 61: 4304–4317.
9.
YanNXuZPQuCH, et al.Dimethyl fumarate improves cognitive deficits in chronic cerebral hypoperfusion rats by alleviating inflammation, oxidative stress, and ferroptosis via NRF2/ARE/NF-κB signal pathway. Int Immunopharmacol2021; 98: 107844.
10.
SuS-HWuY-FLinQ, et al.Fecal microbiota transplantation and replenishment of short-chain fatty acids protect against chronic cerebral hypoperfusion-induced colonic dysfunction by regulating gut microbiota, differentiation of Th17 cells, and mitochondrial energy metabolism. J Neuroinflammation2022; 19: 313.
11.
LinSYLandonBZhangHX, et al.Pericyte dysfunction contributes to vascular cognitive impairment induced by chronic cerebral hypoperfusion in rats. Aging Dis2023; 15: 1357–1372.
12.
HouXLiangXChenJF, et al.Ecto-5′-nucleotidase (CD73) is involved in chronic cerebral hypoperfusion-induced white matter lesions and cognitive impairment by regulating glial cell activation and pro-inflammatory cytokines. Neuroscience2015; 297: 118–126.
13.
SunRHShangJKYanX, et al.VCAM1 Drives vascular inflammation leading to continuous cortical neuronal loss following chronic cerebral hypoperfusion. J Alzheimers Dis2023; 91: 1541–1555.
14.
DejanovicBWuTTsaiM-C, et al.Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer’s disease mouse models. Nature Aging2022; 2: 837–850.
15.
HongSBeja-GlasserVFNfonoyimBM, et al.Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science2016; 352: 712–716.
16.
WangXXZhangBXiaR, et al.Inflammation, apoptosis and autophagy as critical players in vascular dementia. Eur Rev Med Pharmacol Sci2020; 24: 9601–9614.
17.
BellesiMde VivoLChiniM, et al.Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex. J Neurosci2017; 37: 5263–5273.
18.
RajendranLPaolicelliRC. Microglia-mediated synapse loss in Alzheimer's disease. J Neurosci2018; 38: 2911–2919.
19.
ShiDWongJKYZhuK, et al.The anaesthetics isoflurane and xenon reverse the synaptotoxic effects of Aβ1–42 on Megf10-dependent astrocytic synapse elimination and spine density in ex vivo hippocampal brain slices. Int J Mol Sci2025; 24: 912.
20.
Scott-HewittNMahoneyMHuangY, et al.Microglial-derived C1q integrates into neuronal ribonucleoprotein complexes and impacts protein homeostasis in the aging brain. Cell2024; 187: 4193–4212.e4124.
21.
LiLJLuSZhuJ, et al.Astrocytes excessively engulf synapses in a mouse model of Alzheimer’s disease. Int J Mol Sci2024; 25: 1160.
22.
ThionMSGarelS. Microglia under the spotlight: activity and complement-dependent engulfment of synapses. Trends Neurosci2018; 41: 332–334.
23.
JiaJQYangLXChenY, et al.The role of microglial phagocytosis in ischemic stroke. Front Immunol2022; 12: 790201.
24.
ShenHShiXJQiL, et al.Microglia and astrocytes mediate synapse engulfment in a MER tyrosine kinase-dependent manner after traumatic brain injury. Neural Regen Res2023; 18: 1770–1776.
25.
LiSLiuHLvP, et al.Microglia mediate memory dysfunction via excitatory synaptic elimination in a fracture surgery mouse model. J Neuroinflammation2024; 21: 227.
26.
VidyantiANHsiehJYLinKJ, et al.Role of HMGB1 in an animal model of vascular cognitive impairment induced by chronic cerebral hypoperfusion. Int J Mol Sci2020; 21: 2176.
27.
LiuCZhangHGuanR, et al.Inhibition of the HMGB1-RAGE axis attenuates microglial inflammation and ameliorates hypoxia-induced cognitive impairment. Int J Mol Sci2025; 26: 8782.
28.
LiJWangZLiJ, et al.HMGB1: A new target for ischemic stroke and hemorrhagic transformation. Transl Stroke Res2025; 16: 990–1015.
29.
ChenRKangRTangD. The mechanism of HMGB1 secretion and release. Exp Mol Med2022; 54: 91–102.
30.
ShiXWOhtaYLiuX, et al.Chronic cerebral hypoperfusion activates the coagulation and complement cascades in Alzheimer's disease mice. Neuroscience2019; 416: 126–136.
31.
ZhangL-YPanJMamtilahunM, et al.Microglia exacerbate white matter injury via complement C3/C3aR pathway after hypoperfusion. Theranostics2020; 10: 74–90.
32.
Gomez-ArboledasAFonsecaMIKramarE, et al.C5ar1 signaling promotes region- and age-dependent synaptic pruning in models of Alzheimer's disease. Alzheimers Dement2024; 20: 2173–2190.
33.
ZhangCQiHJiaD, et al.Cognitive impairment in Alzheimer's disease FAD(4T) mouse model: synaptic loss facilitated by activated microglia via C1qA. Life Sci2024; 340: 122457.
34.
ShenFSLiuCSunHZ, et al.Emerging evidence of context-dependent synapse elimination by phagocytes in the CNS. J Leukoc Biol2024; 116: 511–522.
35.
LiSLiMLiG, et al.Physical exercise decreases complement-mediated synaptic loss and protects against cognitive impairment by inhibiting microglial Tmem9-ATP6V0D1 in Alzheimer's disease. Aging Cell2025; 24: e14496.
36.
LiuHYJiangMChenZY, et al.The role of the complement system in synaptic pruning after stroke. Aging Dis2024; 16: 1452–1470.
37.
ZhangXZXFJinT. Crocin protects against cerebral- ischemia-induced damage in aged rats through maintaining the integrity of blood-brain barrier. Restor Neurol Neurosci2017; 35: 65–75.
38.
HuangAQJiaLH. Crocin enhances hypothermia therapy in hypoxic ischemia-induced brain injury in mice. Acta Neurol Belg2019; 121: 429–436.
39.
SuWWWangYBShaoS, et al.Crocin ameliorates neuroinflammation and cognitive impairment in mice with Alzheimer's disease by activating PI3K/AKT pathway. Brain Behav2024; 14: e3503.
40.
OrucSGönülYTunayK, et al.The antioxidant and antiapoptotic effects of crocin pretreatment on global cerebral ischemia reperfusion injury induced by four vessels occlusion in rats. Life Sci2016; 154: 79–86.
41.
KapucuA. Crocin ameliorates oxidative stress and suppresses renal damage in streptozotocin induced diabetic male rats. Biotech Histochem2020; 96: 153–160.
42.
HosseinzadehHSadeghniaHRGhaeniFA, et al.Effects of saffron (Crocus sativus L.) and its active constituent, crocin, on recognition and spatial memory after chronic cerebral hypoperfusion in rats. Phytother Res2012; 26: 381–386.
43.
AbeKSaitoH. Effects of saffron extract and its constituent crocin on learning behaviour and long-term potentiation. Phytother Res2000; 14: 149–152.
44.
CuiYZhangZLZhouX, et al.Microglia and macrophage exhibit attenuated inflammatory response and ferroptosis resistance after RSL3 stimulation via increasing Nrf2 expression. J Neuroinflammation2021; 18: 249.
45.
HeLJZhengYHuangLX, et al.Nrf2 regulates the arginase 1 microglia phenotype through the initiation of TREM2 transcription, ameliorating depression-like behavior in mice +. Transl Psychiatry2022; 12: 459.
46.
KangYJHyeonSJMcQuadeA, et al.Neurotoxic microglial activation via IFNγ-induced Nrf2 reduction exacerbating Alzheimer's disease. Adv Sci2024; 11: e2304357.
47.
TangZChenZYGuoM, et al.NRF2 Deficiency promotes ferroptosis of astrocytes mediated by oxidative stress in Alzheimer’s disease. Mol Neurobiol2024; 61: 7517–7533.
48.
Nakano-KobayashiACanelaAYoshiharaT, et al.Astrocyte-targeting therapy rescues cognitive impairment caused by neuroinflammation via the Nrf2 pathway. Proc Natl Acad Sci U S A2023; 120: e2303809120.
49.
HongZXCaoJLiuDD, et al.Celastrol targeting Nedd4 reduces Nrf2-mediated oxidative stress in astrocytes after ischemic stroke. J Pharm Anal2023; 13: 156–169.
50.
R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2021.
51.
KingDHoltKToombsJ, et al.Synaptic resilience is associated with maintained cognition during ageing. Alzheimers Dement2023; 19: 2560–2574.
52.
KumarSReddyPH. The role of synaptic microRNAs in Alzheimer's disease. Biochim Biophys Acta Mol Basis Dis2020; 1866: 165937.
53.
LuXHJiBHuangG, et al.Advances in synaptic PET imaging and intervention with synapse-targeted small-molecular drugs for dementia diagnosis and therapy. Fundam Res2025; 5: 63–71.
54.
VölgyiKGulyássyPTodorovMI, et al.Chronic cerebral hypoperfusion induced synaptic proteome changes in the rat cerebral cortex. Mol Neurobiol2017; 55: 4253–4266.
55.
Leardini-TristãoMAndradeGGarciaC, et al.Correction: physical exercise promotes astrocyte coverage of microvessels in a model of chronic cerebral hypoperfusion. J Neuroinflammation2024; 21: 160.
56.
MiyanoharaJKakaeMNagayasuK, et al.TRPM2 Channel aggravates CNS inflammation and cognitive impairment via activation of microglia in chronic cerebral hypoperfusion. J Neurosci2018; 38: 3520–3533.
57.
HagimoriRAbeMUenoR, et al.Microglial morphological changes and activation in chronic cerebral hypoperfusion are suppressed by lipid peroxidation inhibitor, methyldopa. J Neurochem2025; 169: e70287.
58.
ZhouTLiYXLiXY, et al.Microglial debris is cleared by astrocytes via C4b-facilitated phagocytosis and degraded via RUBICON-dependent noncanonical autophagy in mice. Nat Commun2022; 13: 6233.
59.
BerglundRGuerreiro-CacaisAOAdzemovicMZ, et al.Microglial autophagy-associated phagocytosis is essential for recovery from neuroinflammation. Sci Immunol2020; 5: eabb5077.
60.
LiGSherchanPTangZ, et al.Autophagy & phagocytosis in neurological disorders and their possible cross-talk. Curr Neuropharmacol2021; 19: 1912–1924.
61.
FaustTEGunnerGSchaferDP. Mechanisms governing activity-dependent synaptic pruning in the developing mammalian CNS. Nat Rev Neurosci2021; 22: 657–673.
62.
ChungW-SClarkeLEWangGX, et al.Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature2013; 504: 394–400.
NimmoJByrneRAJDaskoulidouN, et al.The complement system in neurodegenerative diseases. Clin Sci (Lond)2024; 138: 387–412.
73.
AyyubovaGFazalN. Beneficial versus detrimental effects of complement-microglial interactions in Alzheimer's disease. Brain Sci2024; 14: 434.
74.
BatistaAFKhanKAPapavergiMT, et al.The importance of complement-mediated immune signaling in Alzheimer's disease pathogenesis. Int J Mol Sci2024; 25: 817.
75.
TabassumNISelvarajiSFanY, et al.Intermittent fasting reprograms the brain proteome to prevent synaptic degeneration and cognitive impairment in vascular dementia. Theranostics2025; 15: 8429–8450.
76.
HeXDandoOQiuJ. Nrf2 controls homeostatic transcriptional signatures and inflammatory responses in a cell-type specific manner in the adult mouse brain. iScience2025; 28: 113198.
77.
ZhaoWGasterichNClarnerT, et al.Astrocytic Nrf2 expression protects spinal cord from oxidative stress following spinal cord injury in a male mouse model. J Neuroinflammation2022; 19: 134.
78.
Boada-RomeroEGuyCSPalaciosG, et al.Membrane receptors cluster phosphatidylserine to activate LC3-associated phagocytosis. Nat Cell Biol2025; 27: 1676–1687.
79.
SzabóÁVinczeVChhatreAS, et al.LC3-associated Phagocytosis promotes glial degradation of axon debris after injury in Drosophila models. Nat Commun2023; 14: 3077.
80.
PrasharABussiCFearnsA, et al.Lysosomes drive the piecemeal removal of mitochondrial inner membrane. Nature2024; 632: 1110–1117.
81.
PalumbosSDPopolowJGoldsmithJ, et al.Autophagic stress activates distinct compensatory secretory pathways in neurons. Proc Natl Acad Sci U S A2025; 122: e2421886122.
82.
LosierTTKingKERousseauxMWC, et al.Identification of organelle-specific autophagy regulators from tandem CRISPR screens. J Cell Biol2025; 224: e202405138.
83.
LitvinchukASuhJHGuoJL, et al.Amelioration of tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist. Neuron2024; 112: 384–403 e388.
84.
Arbaizar-RovirosaMPedragosaJLozanoJJ, et al.Aged lipid-laden microglia display impaired responses to stroke. EMBO Mol Med2023; 15: e17175.
85.
MarschallingerJIramTZardenetaM, et al.Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci2020; 23: 194–208.
86.
LiLLixiaDGanG, et al.Astrocytic HILPDA promotes lipid droplets generation to drive cognitive dysfunction in mice with sepsis-associated encephalopathy. CNS Neurosci Ther2024; 30: e14758.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
